17:13CRS3123 Achieves High Cure Rates with Low Recurrence in a Phase 2 CDI StudyPeggyLillisFoundation35 views·5 months ago
19:42Patient-centered Outcomes in the Treatment of C. difficile InfectionPeggyLillisFoundation38 views·5 months ago
10:54Recurrences in Clostridioides difficile Infections (rCDI)PeggyLillisFoundation42 views·5 months ago
17:36Lipidomic Changes in Patients with Recurrent C. difficile Infection Pre- and Post-FMTPeggyLillisFoundation45 views·5 months ago
13:45REBYOTA® (fecal microbiota, live – jslm) by Colonoscopy in Adults with rCDIPeggyLillisFoundation98 views·5 months ago
22:02Add-on Therapies (Live Biotherapeutic Products, Monoclonal Antibodies)PeggyLillisFoundation48 views·5 months ago
20:53Colonization and Response to VE303, a Defined Bacterial Consortium for Recurrent CDIPeggyLillisFoundation7 views·5 months ago
23:59Clinical Development of AZD5148 for the Reduction of CDI RecurrencePeggyLillisFoundation22 views·5 months ago
22:12Emerging Antimicrobial Resistance and Need for New Clostridioides difficile-directed AntibioticsPeggyLillisFoundation37 views·5 months ago
22:15Understanding the Real-World Safety of FMT A Decade of Data from a National Centralized Stool BankPeggyLillisFoundation33 views·5 months ago
31:52Diagnostic Testing Window of Vulnerability and Recurrent CDIPeggyLillisFoundation127 views·2 years ago
39:30The Role of Patient Advocates in Guideline Development Panel DiscussionPeggyLillisFoundation100 views·3 years ago